ImmuPharma PLC | Balance Sheet
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,396.30
5,424.00
833.40
3,431.60
2,729.50
4,911.40
Total Accounts Receivable
1,080.60
698.90
1,017.80
2,535.30
1,644.10
943.60
Other Current Assets
29.10
22.50
559.30
-
-
155
Total Current Assets
6,506.00
6,145.40
2,410.50
5,966.80
4,373.60
6,010.10
Net Property, Plant & Equipment
97.10
366.40
280.10
231.90
161.40
164.70
Intangible Assets
602.10
560.50
522.50
511.10
482.30
483
Total Assets
7,205.30
7,072.30
3,213.10
6,709.80
5,017.30
8,657.80
ST Debt & Current Portion LT Debt
346.90
417.90
163.10
143.10
142.40
Accounts Payable
433.80
386.60
637.90
600.30
753.40
Other Current Liabilities
251.20
186.60
440.70
200.90
233.70
Total Current Liabilities
1,031.90
991.00
1,241.70
944.40
1,129.50
Long-Term Debt
769.60
376.00
281.00
219.40
117.30
Provision for Risks & Charges
-
-
-
-
196.00
Total Liabilities
1,801.50
1,367.00
1,522.70
1,163.80
1,442.80
Common Equity (Total)
5,403.70
5,705.40
1,690.40
5,546.00
3,574.50
Total Shareholders' Equity
5,403.70
5,705.40
1,690.40
5,546.00
3,574.50
Total Equity
5,403.70
5,705.40
1,690.40
5,546.00
3,574.50
Liabilities & Shareholders' Equity
7,205.30
7,072.30
3,213.10
6,709.80
5,017.30
About ImmuPharma
View Profile
